Financhill
Back

Harvard Bioscience 10K Form

Sell
21

HBIO
Harvard Bioscience

Last Price:
$0.65
Seasonality Move:
-0.31%

7 Day Trial

ALL ACCESS PASS

$ 7

Receive HBIO News And Ratings

See the #1 stock for the next 7 days that we like better than HBIO

HBIO Financial Statistics

Sales & Book Value

Annual Sales: $94.1M
Cash Flow: $1.3M
Price / Cash Flow: 185.32
Annual Sales: $1.44
Price / Book: 0.48

Profitability

EPS (TTM): -0.29000
Net Income (TTM): $-12.4M
Gross Margin: $54.8M
Return on Equity: -18.36%
Return on Assets: -9.44%

Harvard Bioscience Earnings Forecast

Key Harvard Bioscience Financial Ratios

  • The Gross Profit Margin over the past 27 years for HBIO is 58.18%.
  • The Selling, General & Administrative Expenses for HBIO have been equal to 46.43% of Gross Profit Margin.
  • The Research & Development expenses have been 11.05% of Revenue.
  • The Net Earning history of HBIO is -13.18% of Total Revenues.
  • Per Share Earnings over the last 27 years have been positive in 13 years.

Harvard Bioscience Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Life Sciences Tools & Services
Sector: Health Care
Current Symbol: HBIO
CUSIP: 416906
Website: harvardbioscience.com

Debt

Debt-to-Equity Ratio: 0.58
Current Ratio: 0.82
Quick Ratio: 0.35

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 5.3

HBIO Technical Analysis vs Fundamental Analysis

Sell
21
Harvard Bioscience (HBIO) is a Sell

Is Harvard Bioscience a Buy or a Sell?